Findings from research exploring hypoglycemia, the benefits of behavioral intervention, insulin pump therapy and fetal outcomes in diabetic women are to be presented soon.

- New Findings from Controlled Behavioral Interventions: The Bronx A1c Telephonic Behavioral Intervention Study – Embargoed until time of presentation. Presented by Elizabeth Walker, Ph.D., professor of medicine and of epidemiology and population health, Einstein, at 4:30 pm, June 21. (Abstract # 2-OR, McCormick Place Convention Center, Room W-192B)
- Hypoglycemia in Hospitalized Patients; Etiology and Prevention – Is Hypoglycemia a Marker or Cause of Death? – Embargoed until 10 am, June 22. Presented by Joel Zonszein, M.D., director, Clinical Diabetes Center, and professor of clinical medicine, Einstein, at 8 am, June 22. (Symposium # AC-SY11, McCormick Place Convention Center W-375 )
- Resveratrol Improves Insulin Sensitivity in Concert with Reduced Inflammation and "Browning" of White Adipose Tissue in Obese, Insulin Resistant Humans – Embargoed until time of presentation. Presented by Meredith Hawkins, M.D., the Harold and Muriel Block Chair in Medicine at Einstein, and attending physician, endocrinology, Montefiore, at 9:15 am, June 22. (Abstract #99-OR, McCormick Place Convention Center West Bldg. Room W-192B)
Advertisement